Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Xếp hạng trong cổ phiếu #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Giá cổ phiếu
$0.2488447
Đồng bộ lần cuối: 2024-10-01
Vốn hóa thị trường
$2.01M
Thay đổi (1 ngày)
-1.88%
Thay đổi (1 năm)
0.00%
Quốc gia
IN
Giao dịch Ortin Laboratories Limited (ORTINLAB)

Danh mục

Doanh thu của Ortin Laboratories Limited (ORTINLAB)
Doanh thu vào Jun 2024 TTM: $89.95K
Theo các báo cáo tài chính gần đây của Ortin Laboratories Limited, doanh thu hiện tại của công ty (TTM) là $89.95K. Trong năm 2023, công ty đạt doanh thu $732.57K giảm so với doanh thu năm 2022, là $1.08M. Doanh thu là tổng số tiền công ty tạo ra từ việc bán hàng hóa hoặc dịch vụ. Không giống như lợi nhuận, doanh thu không trừ chi phí.
Lịch sử doanh thu của Ortin Laboratories Limited từ 2008 đến 2026
Doanh thu vào cuối mỗi năm
Năm Doanh thu Thay đổi
2026 (TTM) $89.95K -64.48%
2024 $253.23K -65.43%
2023 $732.57K -32.44%
2022 $1.08M -2.82%
2021 $1.12M -95.72%
2020 $26.04M 10.75%
2019 $23.51M 92.06%
2018 $12.24M 87.73%
2017 $6.52M 8.62%
2016 $6.00M -4.55%
2015 $6.29M -33.47%
2014 $9.45M -12.98%
2013 $10.86M -35.79%
2012 $16.92M 20.37%
2011 $14.06M 101.43%
2010 $6.98M 19.15%
2009 $5.86M -19.40%
2008 $7.27M 0.00%
Doanh thu của các công ty hoặc đối thủ tương tự